Viva Biotech Non-Executive Director Stephen Wang Resigns With Immediate Effect

Viva Biotech Holdings ( (HK:1873) ) has issued an announcement.

Viva Biotech Holdings announced the immediate resignation of non-executive director Stephen Hui Wang, who is stepping down to devote more time to his personal and business commitments. The board emphasized that Wang has no disagreements with the company or its directors, that there are no issues requiring shareholder attention arising from his departure, and expressed gratitude for his contributions while confirming the board’s composition following the change.

The resignation underscores ongoing board refreshment at the Hong Kong–listed biotech firm, but the absence of reported disputes or governance concerns suggests limited operational disruption and a largely orderly transition for investors and other stakeholders.

The most recent analyst rating on (HK:1873) stock is a Hold with a HK$2.50 price target. To see the full list of analyst forecasts on Viva Biotech Holdings stock, see the HK:1873 Stock Forecast page.

More about Viva Biotech Holdings

Viva Biotech Holdings is a Hong Kong–listed company that operates in the biotechnology sector, overseen by a board comprising executive, non-executive, and independent non-executive directors. The company’s governance structure reflects a mix of management leadership and external oversight, typical of listed life sciences and biotech service providers targeting global and regional markets.

Average Trading Volume: 8,253,183

Technical Sentiment Signal: Buy

Current Market Cap: HK$4.89B

For a thorough assessment of 1873 stock, go to TipRanks’ Stock Analysis page.